Apo-Semaglutide Injection : Incorrect dose display
OFFICIAL-SOURCE RECALL · CANADA
Apo-Semaglutide Injection : Incorrect dose display Recall: The affected lot may display a 2 mg dose in the
Use the identifiers printed on your item to determine whether this recall may affect the product you own.
CountryCanadaPublishedAugust 27, 2026Last updatedAugust 27, 2026Official source last checkedAugust 27, 2026 at 6:25 PM UTC
CHECK THE ITEM YOU OWN
Is your product affected?
- Brand
- See official notice
- Product
- Apo-Semaglutide Injection : Incorrect dose display
- Manufacturer
- See official notice
- Lot number
- may
The barcode may identify the product type, while the recall may apply only to certain lots, dates or variants. Check all identifiers listed in the official recall.
Why this product was recalled
The affected lot may display a 2 mg dose in the dose window and deliver a 2 mg dose instead of the expected 0.25 mg or 0.5 mg dose.
Hazard
The affected lot may display a 2 mg dose in the dose window and deliver a 2 mg dose instead of the expected 0.25 mg or 0.5 mg dose.
Official recall notice
Apo-Semaglutide Injection : Incorrect dose display
Agency: Health Canada
Official publication date: August 27, 2026
Read the official CANADA_HEALTH recall notice →SCAN ONCE. KEEP WATCHING.
Keep an eye on the products at home.
Scan food and household product barcodes, save your items and get notified when a future recall may match.
